Latest Insider Trades
Open-market buys and sells in the newest SEC filings, one row per filing and side. Filings through 2026-11-16 21:54 ET, updated 2026-11-17 05:09 UTC.
Download CSV Up to 5,000 rows
9522 trades found
| Filed | Traded | Company | Insider | Role | Side | Shares | Avg price | Value | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 2024-02-26 | 2024-02-22 |
ALLE
Allegion plc
|
Stone John H | CEO | Buy | 10,000 | 132.41 | $1.3M | SEC filing for Stone John H (opens in a new tab) |
| 2024-02-23 | 2024-02-16 |
IHT
INNSUITES HOSPITALITY TRUST
|
WIRTH JAMES F | CEO | Buy | 878 | 1,231.64 | $1.1M | SEC filing for WIRTH JAMES F (opens in a new tab) |
| 2024-02-22 | 2024-02-21 |
EXEL
EXELIXIS, INC.
|
JOHNSON DAVID EDWARD | Director | Buy | 190,000 | 20.70 | $3.9M | SEC filing for JOHNSON DAVID EDWARD (opens in a new tab) |
| 2024-02-22 | 2024-02-20 |
FCNCA
FIRST CITIZENS BANCSHARES INC /DE/
|
BRYANT HOPE HOLDING | Chair | Buy | 766 | 1,314.97 | $1.0M | SEC filing for BRYANT HOPE HOLDING (opens in a new tab) |
| 2024-02-22 | 2024-02-20 |
ADC
AGREE REALTY CORP
|
RAKOLTA JOHN JR | Director | Buy | 20,102 | 56.75 | $1.1M | SEC filing for RAKOLTA JOHN JR (opens in a new tab) |
| 2024-02-20 | 2024-02-20 |
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
|
MCPEAK MERRILL A | Director | Buy | 250,000 | 9.15 | $2.3M | SEC filing for MCPEAK MERRILL A (opens in a new tab) |
| 2024-02-20 | 2024-02-16 |
CRMT
AMERICAS CARMART INC
|
MAGNOLIA CAPITAL FUND, LP | 10% owner | Buy | 23,105 | 61.60 | $1.4M | SEC filing for MAGNOLIA CAPITAL FUND, LP (opens in a new tab) |
| 2024-02-20 | 2024-02-15 |
MNKTQ
Keenova Therapeutics plc
|
GOLDENTREE ASSET MANAGEMENT LP | 10% owner | Buy | 225,000 | 38.25 | $8.6M | SEC filing for GOLDENTREE ASSET MANAGEMENT LP (opens in a new tab) |
| 2024-02-20 | 2024-02-16 |
ADC
AGREE REALTY CORP
|
RAKOLTA JOHN JR | Director | Buy | 20,430 | 57.00 | $1.2M | SEC filing for RAKOLTA JOHN JR (opens in a new tab) |
| 2024-02-16 | 2024-02-14 |
SOC
Sable Offshore Corp.
|
Flores James Caldwell | President | Buy | 300,000 | 10.00 | $3.0M | SEC filing for Flores James Caldwell (opens in a new tab) |
| 2024-02-16 | 2020-04-01 1416 days late |
TELA
TELA Bio, Inc.
|
EW HEALTHCARE PARTNERS FUND 2, L.P. | 10% owner | Buy | 326,062 | 9.32 | $3.0M | SEC filing for EW HEALTHCARE PARTNERS FUND 2, L.P. (opens in a new tab) |
| 2024-02-16 | 2024-02-15 |
AYX
Alteryx, Inc.
|
Stoecker Dean | Director | Buy | 42,500 | 47.90 | $2.0M | SEC filing for Stoecker Dean (opens in a new tab) |
| 2024-02-16 | 2024-02-14 |
EMKR
EMCORE CORP
|
Archon Capital Management LLC | 10% owner | Buy | 4,851,568 | 0.37 | $1.8M | SEC filing for Archon Capital Management LLC (opens in a new tab) |
| 2024-02-14 | 2024-02-12 |
MLYS
Mineralys Therapeutics, Inc.
|
Samsara BioCapital, L.P. | 10% owner | Buy | 555,555 | 13.50 | $7.5M | SEC filing for Samsara BioCapital, L.P. (opens in a new tab) |
| 2024-02-14 | 2024-02-12 |
KYTX
Kyverna Therapeutics, Inc.
|
Vida Ventures, LLC | 10% owner | Buy | 253,136 | 22.00 | $5.6M | SEC filing for Vida Ventures, LLC (opens in a new tab) |
| 2024-02-14 | 2024-02-12 |
KYTX
Kyverna Therapeutics, Inc.
|
Bain Capital Life Sciences Investors, LLC | 10% owner | Buy | 450,000 | 22.00 | $9.9M | SEC filing for Bain Capital Life Sciences Investors, LLC (opens in a new tab) |
| 2024-02-14 | 2024-02-12 |
TNYA
Tenaya Therapeutics, Inc.
|
COLUMN GROUP III-A, LP | 10% owner | Buy | 2,222,222 | 4.50 | $10.0M | SEC filing for COLUMN GROUP III-A, LP (opens in a new tab) |
| 2024-02-14 | 2024-02-12 |
TNYA
Tenaya Therapeutics, Inc.
|
GOEDDEL DAVID V | Director | Buy | 2,222,222 | 4.50 | $10.0M | SEC filing for GOEDDEL DAVID V (opens in a new tab) |
| 2024-02-14 | 2024-02-13 |
COOP
Maverick Merger Sub 2, LLC
|
Weinbach Michael S | President | Buy | 17,000 | 71.16 | $1.2M | SEC filing for Weinbach Michael S (opens in a new tab) |
| 2024-02-14 | 2024-02-13 |
WT
WisdomTree, Inc.
|
Steinberg Jonathan L | CEO | Buy | 303,781 | 7.20 | $2.2M | SEC filing for Steinberg Jonathan L (opens in a new tab) |
| 2024-02-13 | 2024-02-01 |
AYX
Alteryx, Inc.
|
Stoecker Dean | Director | Buy | 35,000 | 47.46 | $1.7M | SEC filing for Stoecker Dean (opens in a new tab) |
| 2024-02-12 | 2024-02-08 |
JSPR
Jasper Therapeutics, Inc.
|
TC Group, LLC | 10% owner | Buy | 190,000 | 12.95 | $2.5M | SEC filing for TC Group, LLC (opens in a new tab) |
| 2024-02-12 | 2024-02-12 |
KYTX
Kyverna Therapeutics, Inc.
|
Rubin Michael P. | Other | Buy | 450,000 | 22.00 | $9.9M | SEC filing for Rubin Michael P. (opens in a new tab) |
| 2024-02-12 | 2024-02-08 |
SANA
Sana Biotechnology, Inc.
|
NELSEN ROBERT | Director | Buy | 1,090,909 | 5.50 | $6.0M | SEC filing for NELSEN ROBERT (opens in a new tab) |
| 2024-02-12 | 2024-02-08 |
SANA
Sana Biotechnology, Inc.
|
CRANDELL KEITH | 10% owner | Buy | 1,090,909 | 5.50 | $6.0M | SEC filing for CRANDELL KEITH (opens in a new tab) |
| 2024-02-12 | 2024-02-08 |
SANA
Sana Biotechnology, Inc.
|
ARCH Venture Fund IX, L.P. | 10% owner | Buy | 1,090,909 | 5.50 | $6.0M | SEC filing for ARCH Venture Fund IX, L.P. (opens in a new tab) |
| 2024-02-12 | 2024-02-08 |
SLSN
SOLESENCE, INC.
|
WHITMORE BRADFORD T | 10% owner | Buy | 3,824,864 | 0.40 | $1.5M | SEC filing for WHITMORE BRADFORD T (opens in a new tab) |
| 2024-02-12 | 2024-02-09 |
VFC
V F CORP
|
Darrell Bracken | President | Buy | 65,360 | 15.38 | $1.0M | SEC filing for Darrell Bracken (opens in a new tab) |
| 2024-02-09 | 2024-02-08 |
JSPR
Jasper Therapeutics, Inc.
|
VENKATARAMAN BALAJI | 10% owner | Buy | 350,000 | 12.95 | $4.5M | SEC filing for VENKATARAMAN BALAJI (opens in a new tab) |
| 2024-02-09 | 2024-02-07 |
AON
Aon plc
|
KNIGHT LESTER B | Director | Buy | 25,000 | 301.97 | $7.5M | SEC filing for KNIGHT LESTER B (opens in a new tab) |
| 2024-02-08 | 2024-02-06 |
KALV
KalVista Pharmaceuticals, Inc.
|
Koh Bong Y | 10% owner | Buy | 86,048 | 14.62 | $1.3M | SEC filing for Koh Bong Y (opens in a new tab) |
| 2024-02-08 | 2024-02-06 |
LCTX
Lineage Cell Therapeutics, Inc.
|
BRADSHER NEAL C | Director | Buy | 6,730,770 | 1.04 | $7.0M | SEC filing for BRADSHER NEAL C (opens in a new tab) |
| 2024-02-08 | 2024-02-06 |
ANRO
Alto Neuroscience, Inc.
|
Alpha Wave Global, LP | 10% owner | Buy | 600,000 | 16.00 | $9.6M | SEC filing for Alpha Wave Global, LP (opens in a new tab) |
| 2024-02-07 | 2024-02-05 |
CRMT
AMERICAS CARMART INC
|
MAGNOLIA CAPITAL FUND, LP | 10% owner | Buy | 42,149 | 60.20 | $2.5M | SEC filing for MAGNOLIA CAPITAL FUND, LP (opens in a new tab) |
| 2024-02-07 | 2024-02-07 |
OPK
OPKO HEALTH, INC.
|
FROST PHILLIP MD ET AL | CEO | Buy | 1,500,000 | 0.98 | $1.5M | SEC filing for FROST PHILLIP MD ET AL (opens in a new tab) |
| 2024-02-07 | 2024-02-06 |
CHTR
CHARTER COMMUNICATIONS, INC. /MO/
|
Winfrey Christopher L | CEO | Buy | 5,050 | 295.29 | $1.5M | SEC filing for Winfrey Christopher L (opens in a new tab) |
| 2024-02-06 | 2024-02-06 |
CVBF
CVB FINANCIAL CORP
|
Borba George A Jr | Director | Buy | 59,601 | 16.78 | $1.0M | SEC filing for Borba George A Jr (opens in a new tab) |
| 2024-02-05 | 2024-02-01 |
SMCI
Super Micro Computer, Inc.
|
CHAN SHIU LEUNG | Director | Buy | 2,000 | 568.00 | $1.1M | SEC filing for CHAN SHIU LEUNG (opens in a new tab) |
| 2024-02-02 | 2024-02-02 |
BBXIB
BBX Capital, Inc.
|
LEVAN JARETT | CEO | Buy | 415,395 | 11.08 | $4.6M | SEC filing for LEVAN JARETT (opens in a new tab) |
| 2024-02-01 | 2024-01-30 |
VERA
Vera Therapeutics, Inc.
|
Katabi Maha | Director | Buy | 161,290 | 31.00 | $5.0M | SEC filing for Katabi Maha (opens in a new tab) |
| 2024-02-01 | 2024-01-30 |
AVBP
ArriVent BioPharma, Inc.
|
HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10% owner | Buy | 555,555 | 18.00 | $10.0M | SEC filing for HILLHOUSE INVESTMENT MANAGEMENT, LTD. (opens in a new tab) |
| 2024-02-01 | 2024-01-30 |
KALV
KalVista Pharmaceuticals, Inc.
|
Koh Bong Y | 10% owner | Buy | 88,099 | 14.47 | $1.3M | SEC filing for Koh Bong Y (opens in a new tab) |
| 2024-02-01 | 2024-01-31 |
QNBC
QNB CORP.
|
Bimes Randy S. | Director | Buy | 48,978 | 25.66 | $1.3M | SEC filing for Bimes Randy S. (opens in a new tab) |
| 2024-01-31 | 2024-01-29 |
CGON
CG Oncology, Inc.
|
Song Hong Fang | Director | Buy | 263,157 | 19.00 | $5.0M | SEC filing for Song Hong Fang (opens in a new tab) |
| 2024-01-31 | 2024-01-29 |
CGON
CG Oncology, Inc.
|
Cui Xiangmin | 10% owner | Buy | 400,000 | 19.00 | $7.6M | SEC filing for Cui Xiangmin (opens in a new tab) |
| 2024-01-31 | 2024-01-30 |
AVBP
ArriVent BioPharma, Inc.
|
ORBIMED ADVISORS LLC | Director | Buy | 222,222 | 18.00 | $4.0M | SEC filing for ORBIMED ADVISORS LLC (opens in a new tab) |
| 2024-01-31 | 2024-01-30 |
AVBP
ArriVent BioPharma, Inc.
|
GORDON CARL L | Director | Buy | 222,222 | 18.00 | $4.0M | SEC filing for GORDON CARL L (opens in a new tab) |
| 2024-01-31 | 2024-01-30 |
AVBP
ArriVent BioPharma, Inc.
|
HEALY JAMES | Director | Buy | 444,444 | 18.00 | $8.0M | SEC filing for HEALY JAMES (opens in a new tab) |
| 2024-01-31 | 2024-01-30 |
EPSN
Epsilon Energy Ltd.
|
Stabell Jason | CEO | Buy | 245,200 | 4.82 | $1.2M | SEC filing for Stabell Jason (opens in a new tab) |
| 2024-01-31 | 2024-01-29 |
TRML
Tourmaline Bio, Inc.
|
MCDADE MARK | Director | Buy | 100,000 | 32.50 | $3.2M | SEC filing for MCDADE MARK (opens in a new tab) |